Anduril Raises $5B, Googlebook vs. MacBook Neo | OWITH Daily

Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world. In a remarkable display of the growing impact of artificial intelligence, Isomorphic Labs and Anduril have secured substantial investments in their latest funding rounds. Isomorphic Labs, an AI-driven drug discovery company, raised $2.1 billion in a Series B round, while defense technology company Anduril announced a $5 billion Series H round. Both rounds were led by Thrive Capital. These achievements underscore the transformative potential of AI across diverse sectors. Isomorphic Labs focuses on outcomes in drug discovery, highlighting that the results in this field are more critical than the algorithms used. Meanwhile, Anduril emphasizes its capability to deploy advanced technologies effectively in defense scenarios, which is crucial in today's global context. Transitioning to developments in venture capital and acquisitions, Exaforce has raised $125 million for cybersecurity innovations, and Rosebank Industries acquired CPM Holdings for $2.1 billion. The acquisition of AI document processing platform Rossum by Coupa further demonstrates the ongoing interest in AI solutions across various industries. Additionally, A Star has announced a $450 million fund for seed-stage tech investments. The tech landscape is witnessing significant changes as institutions and companies adapt to new challenges. Princeton University has made a historic decision to require proctors for in-person exams starting July 1st due to concerns about AI-assisted cheating. This marks a major shift in its honor system since 1893, reflecting the challenges posed by AI chatbots in maintaining academic integrity. On the hardware front, Google has unveiled its new line of laptops, "Googlebook," set to compete with Apple's MacBook Neo. These laptops will integrate Google's Android and ChromeOS into a unified operating system, optimizing Google's AI suite, "Gemini Intelligence." The launch comes amidst a global memory shortage and trade tensions that could influence pricing strategies. In legal news, the ongoing Altman v. Musk trial has revealed Elon Musk's past ambitions for control over OpenAI's proposed for-profit arm. This trial examines whether OpenAI deviated from its charitable mission by restructuring into a public-benefit corporation. Meanwhile, Anthropic is reportedly fundraising at a staggering $950 billion valuation, emphasizing the intense competition and investment within the AI sector. Additional updates include Waymo recalling robotaxis due to software issues and Samsung facing potential labor strikes over pay disputes. Foxconn recently dealt with a cyberattack at its North American facilities. Turning to international relations, President Donald Trump's visit to Beijing with 17 CEOs marks a significant diplomatic engagement between the U.S. and China. Although substantial policy breakthroughs are not anticipated, the visit aims to deescalate tensions and normalize trade relations between these two economic giants. Among the CEOs accompanying Trump are Elon Musk of Tesla and Tim Cook of Apple. While major trade policy changes are unlikely, discussions are expected to focus on securing trade deals in non-strategic sectors like commodities and aircraft transactions. The existing one-year trade truce from October 2025 is likely to continue or be extended. In this context, artificial intelligence emerges as a central issue in U.S.-China relations, shifting the focus from trade to tech rivalry. Both nations are employing export controls—advanced semiconductors for the U.S., rare earths for China—as economic tools. Global markets reflect optimism with an uptick in anticipation of these talks, while Amazon employees engage competitively on AI leaderboards in what analysts term "tokenmaxxing." Meanwhile, India's Prime Minister Narendra Modi reinstates COVID-era work-from-home policies amid disruptions caused by the Iran conflict. GlobaSupport the showThanks for listening! Follow us on Twitter, Instagram and Linkedin